Select Page
Home » Oral Dose » Softgel Technologies » Plant Based Softgel Technology

Plant Based Softgel Technology

EXPANDING THE RANGE OF FILL FORMULATIONS INTO SOFTGELS

As the inventor of softgel rotary die process, Catalent continues to lead the softgel industry with cutting-edge drug delivery innovations. Our award-winning soft capsule technology platform, OptiShell® Technology, further advances RP Scherer Softgel technology by providing development solutions for challenging drug compounds contained within complex fill formulations.

OptiShell capsules utilize a patented shell derived from plant polysaccharides that are ideally suited for the encapsulation of higher melting point fill formulations. Soft capsules containing semi-solid matrices for modified release of poorly soluble and/or poorly permeable drug compounds are now an option, only at Catalent! For immediate release applications, OptiShell technology expands the range of compatible excipients available for developing lipid-based capsule formulations, providing more solutions for solving unique drug delivery challenges.

OptiShell technology and Catalent RP Scherer Softgels combined enable encapsulation of broadened range of lipid-based formulations.

Back to top

CATALENT BENEFITS

  • Improves bioavailability for a greater number of poorly water-soluble and poorly permeable compounds
  • Modified or extended release of compounds from softgels
  • Solves complex development and formulation challenges beyond conventional softgel technology
  • Patented shell composition can handle:
    • Encapsulation of  high temperature fill formulations (up to 70˚C) for semi-solid and highly viscous fill formulations
    • Higher pH fill formulations
    • A wider range of compatible fill excipients for enhancing drug bioavailability and stability

Back to top

VALUABLE PRODUCT DIFFERENTIATION

  • Proprietary technology and process with strong IP protection
  • Better patient adherence – easy to swallow
  • Gelatin-free products for expanded markets
  • Elimination of  shell odor and a non-distinguishing taste

Back to top

CATALENT CAPABILITIES

We have a long track record of customizing successful programs involving our proprietary advanced technologies:

  • Pre-formulation and feasibility studies
  • Solubility screening of New Chemical Entities
  • Softgel capsule fill formulation development
  • Small-scale lab encapsulation for early stability data and final formulation selection
  • Shell development
  • Strong IP (intellectual property) positions including fill formulations for improved bioavailability
  • Extensive technical support in softgel capsule product development
  • Reliable supply from clinical phases to commercial manufacturing
  • Contingency planning and quality assurance via our large global network

Back to top

FACILITIES

Our deep formulation expertise supported by a global infrastructure of cGMP, FDA, EMA and locally accredited softgel facilities will provide a catalyst to your success by tailoring a unique drug delivery solution to bring your product faster to market.